Biomab 50mg Nimotuzumab Injection

Biomab 50mg Nimotuzumab Injection is a prescription targeted therapy used in the treatment of certain cancers, including head and neck cancer and specific types of brain tumors. It contains Nimotuzumab, a monoclonal antibody that targets the epidermal growth factor receptor (EGFR), a protein involved in the growth and spread of cancer cells. By blocking EGFR activity, Biomab 50mg Nimotuzumab Injection helps slow tumor growth and may enhance the effectiveness of radiation therapy or chemotherapy when used as part of a comprehensive treatment plan. Administered as an intravenous infusion under the supervision of an oncology specialist, it requires regular monitoring to assess treatment response and manage potential side effects. Patients should use Biomab 50mg Nimotuzumab Injection only as prescribed by their healthcare provider.